MMP-21 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-MMP21
In stock
- SKU
- REC-MMP21
Target Overview
MMP-21 (Matrix metalloproteinase-21; UniProt Q8N119; gene MMP21) is a secreted zinc-dependent endopeptidase belonging to the metzincin superfamily of matrix metalloproteinases. The full-length human sequence spans 569 amino acids and encodes a signal peptide, a propeptide domain containing the cysteine-switch motif, a catalytic domain with the conserved HEXXHXXGXXH zinc-binding sequence, and a hemopexin-like C-terminal domain. This recombinant form is produced in HEK293 mammalian cells, which supports the glycosylation patterns and folding characteristics appropriate for a secreted MMP, yielding material well suited to functional enzyme assays and biophysical characterisation. Documented substrates include alpha-1-antitrypsin, making this recombinant suitable for direct cleavage assays using native or fluorogenic alpha-1-antitrypsin-derived peptide substrates. MMP-21 has also been characterised as a candidate negative regulator of NOTCH signalling, providing a rationale for co-incubation studies examining NOTCH pathway component processing. Researchers use this recombinant protein primarily in three contexts: (1) enzymatic activity assays to characterise substrate specificity and kinetic parameters (Km, kcat, kcat/Km); (2) small-molecule inhibitor screening and IC50 determination, particularly for broad-spectrum or MMP-selective hydroxamate and carboxylate inhibitors; and (3) antibody validation, where a well-characterised recombinant serves as a positive-control antigen for Western blot and immunohistochemistry. Researchers running antibody validation experiments can pair this recombinant directly with the Triple Point Biologics matched antibody (catalog RP-MMP21), which has been validated for Western blot against human MMP-21.
Background
Applications
- Fluorogenic peptide substrate cleavage assay to determine MMP-21 catalytic activity (Km, kcat)
- Alpha-1-antitrypsin cleavage assay to characterise MMP-21 substrate specificity
- Small-molecule MMP inhibitor IC50 determination in a defined single-enzyme format
- Antibody validation positive control for Western blot using matched antibody RP-MMP21
- NOTCH pathway component processing assay to investigate MMP-21 as a candidate negative regulator
- Recombinant substrate for mass spectrometry-based identification of MMP-21 cleavage sites (degradomics)
- Protein–protein interaction studies examining MMP-21 binding partners in the LR-patterning pathway
- SPR or BLI biophysical binding assay with candidate endogenous inhibitors (TIMPs)
References
- Chen Q et al. Functional analysis of novel MMP21 gene compound heterozygous mutations in a prenatal case with heterotaxy. Hum Mol Genet. 2025. doi:10.1093/hmg/ddaf122 (PMID 40679208)
- Pasquetti D et al. Expanding the Molecular Spectrum of MMP21 Missense Variants: Clinical Insights and Literature Review. Genes (Basel). 2025. doi:10.3390/genes16010062 (PMID 39858609)
- Szenker-Ravi E et al. CIROZ is dispensable in ancestral vertebrates but essential for left-right patterning in humans. Am J Hum Genet. 2025. doi:10.1016/j.ajhg.2024.12.006 (PMID 39753129)
- Perrot A. Human Genetics of Defects of Situs. Adv Exp Med Biol. 2024. doi:10.1007/978-3-031-44087-8_42 (PMID 38884744)
- Nakai K et al. Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB–MMP21 pathway. Nat Commun. 2023. doi:10.1038/s41467-023-42774-6 (PMID 37923722)
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Secreted; Extracellular matrix |
Frequently Asked Questions
What molecular weight band should I expect for recombinant MMP-21 on SDS-PAGE or Western blot?
The full-length human MMP-21 sequence is 569 amino acids, giving a predicted unglycosylated molecular weight of approximately 63 kDa. Because this recombinant is produced in HEK293 cells, N-linked glycosylation adds heterogeneous mass, so the observed band on reducing SDS-PAGE typically runs at 70–80 kDa. Under non-reducing conditions, expect a similar position unless disulfide-linked dimers are present. When using our matched antibody RP-MMP21 for Western blot, a band in the 70–80 kDa range serves as the expected positive control signal.
What processing or activation state is this recombinant MMP-21 supplied in — zymogen or active form?
REC-MMP21 is supplied as the active enzyme form; the propeptide cysteine-switch has been removed during processing, exposing the functional catalytic domain. It is not a zymogen requiring exogenous activation with APMA. The catalytic domain retains the conserved HEXXHXXGXXH zinc-binding motif characteristic of MMP family members. If your assay design requires a latent zymogen as a control, this product is not appropriate for that purpose — it is intended for direct functional and binding experiments.
What substrate should I use to measure MMP-21 proteolytic activity in a fluorogenic assay?
The best-characterised natural substrate for MMP-21 is alpha-1-antitrypsin. For fluorogenic assays, a generic broad-spectrum MMP substrate such as Mca-PLGL-Dpa-AR-NH2 (Knight substrate) is commonly used and is cleaved by MMP-21 in vitro. Alpha-1-antitrypsin-derived peptides can also be used for native cleavage assays resolved by SDS-PAGE. Assay buffer should match REC-MMP21's storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2 — to maintain zinc-dependent catalytic activity. Include 0.05% Brij-35 to prevent nonspecific surface adsorption at low enzyme concentrations.
What starting concentration of recombinant MMP-21 should I use in an activity assay?
A practical starting point is 1–10 nM REC-MMP21 in the assay well for fluorogenic substrate experiments, with substrate concentrations ranging from 5–50 µM to bracket the expected Km. For cleavage assays with native alpha-1-antitrypsin resolved by SDS-PAGE, 100–500 ng of enzyme per reaction is a reasonable starting range at a 1:10 to 1:50 enzyme-to-substrate molar ratio. Titrate enzyme concentration empirically, as specific activity can vary with lot. Always include a no-enzyme blank and a metalloproteinase inhibitor control (e.g., 10 mM EDTA or 1 µM marimastat) to confirm zinc-dependent activity.
How does calcium in the storage buffer affect MMP-21 activity assay buffer design?
REC-MMP21 is stored in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl2. The calcium is essential for MMP catalytic domain stability — do not use EGTA or EDTA-containing buffers, as chelation will inhibit the enzyme. When diluting into assay buffer, maintain at least 1–5 mM CaCl2 in the final assay volume. Glycerol dilution from the stock is generally tolerable at ≤1% in the final reaction. Zinc supplementation (1–10 µM ZnCl2) can be added if activity appears lower than expected after dilution.
Can I use REC-MMP21 as a positive control for Western blot with the RP-MMP21 antibody?
Yes — REC-MMP21 and RP-MMP21 are produced as a matched pair specifically for this purpose. Load 20–50 ng of REC-MMP21 per lane on a 10% or 12% SDS-PAGE gel under reducing conditions. After transfer and blocking, RP-MMP21 should detect the recombinant at 70–80 kDa (HEK293-glycosylated form). This loading range gives a clean, non-saturated band that can be used alongside cell lysate lanes to confirm antibody performance. The antibody has been validated against this recombinant in-house, so band identity is not ambiguous.
How much recombinant MMP-21 should I load for a Western blot positive control lane alongside tissue lysates?
Load 25–50 ng of REC-MMP21 per lane. At this amount, RP-MMP21 (used at a 1:1000–1:2000 primary antibody dilution) produces a robust signal at 70–80 kDa on standard PVDF or nitrocellulose membranes with HRP-conjugated secondary antibodies and ECL detection. Loading more than 100 ng risks signal bleed into adjacent sample lanes. If your tissue lysate is from a MMP-21-low source, reducing the recombinant load to 10–20 ng helps avoid a disproportionately dominant positive control band that obscures relative quantitation.
What is the best way to store and handle REC-MMP21 to avoid loss of activity after receipt?
Upon receipt, centrifuge briefly to collect liquid, then aliquot immediately into single-use volumes appropriate for your typical experiment — avoid working from a master tube repeatedly. Store at -20°C; the 10% glycerol in the buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2) provides cryoprotection without requiring -80°C. Shelf life at -20°C in unopened aliquots is 12 months from date of manufacture. For working dilutions, prepare fresh in assay buffer on ice and use within 4 hours; dilute protein below 10 µg/mL can adsorb to tube walls — adding 0.1% BSA (protease-free) to dilution buffer mitigates this.
Validation imagery coming soon
Western blot validation figures for REC-MMP21 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.